Guidelines for ATC classification and DDD assignment - WHOCC

Combinations of corticosteroids and antiinfectives for gynaecological
use, see G01B.
Corticosteroids for local oral treatment, see A01AC.
Anti-acne preparations, see D10A.
Antihemorrhoidals with corticosteroids, see C05AA.
Corticosteroids for ophthalmological or otological use, see S - Sensory
organs.
D07A CORTICOSTEROIDS, PLAIN
The group is subdivided according to clinical potency of the steroids as
such. Additional agents meant to enhance the penetration and increase
the potency of the product do not influence the classification, neither do
the strength of the preparations or the vehicle.
D07AA Corticosteroids, weak (group I)
D07AB Corticosteroids, moderately potent (group II)
D07AC Corticosteroids, potent (group III)
D07AD Corticosteroids, very potent (group IV)
D07B CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS
This group comprises combined corticosteroid/antiseptic preparations
for dermatological use.
For most antifungal preparations with corticosteroids, the primary
indication is mycosis and not inflammation. These products should be
classified in D01A - Antifungals for topical use. Corticosteroids,
antiseptics and salicylic acid in combination are classified in D07X.
The group is subdivided according to clinical potency, see D07A.
Exceptions, see D07. At each 5th level various antiseptics may occur.
D07BA Corticosteroids, weak, combinations with antiseptics
133